<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01063361</url>
  </required_header>
  <id_info>
    <org_study_id>09-192</org_study_id>
    <nct_id>NCT01063361</nct_id>
  </id_info>
  <brief_title>Low Glycemic Index Diets (With Pulses) in Type 2 Diabetes</brief_title>
  <official_title>Effect of Low Glycemic Index Diets (With Pulses) on Glucose Control in Non-Insulin Dependent Diabetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Saskatchewan Pulse Growers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pulse Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Healthy individuals with type 2 diabetes will receive intensive counseling on food selection&#xD;
      to improve glucose control using either high cereal fiber dietary strategies or low glycemic&#xD;
      index foods emphasizing dried legumes and their products. The treatments will last 3 months&#xD;
      with bloods taken for HbA1c, glucose and blood lipids. If the study shows a benefit for&#xD;
      either or both diets, then use of high fiber and/or low glycemic index foods in the diet may&#xD;
      provide another potential way to improve glucose control and lower cholesterol levels in&#xD;
      non-insulin dependent diabetes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in HbA1c</measure>
    <time_frame>from prestudy and week 0, to end of treatment weeks 8, 10, and 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum lipids</measure>
    <time_frame>from prestudy and week 0, to end of treatment weeks 8, 10, and 12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>fasting glucose</measure>
    <time_frame>from prestudy and week 0, to end of treatment weeks 8, 10, and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in weight, waist and hip circumference</measure>
    <time_frame>weeks 0, 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>from prestudy and week 0, to end of treatment weeks 8, 10, and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>creatine, urea, and c-peptides in 24 hour urine collection</measure>
    <time_frame>0, 12 weeks.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">131</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Low glycemic Index Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low glycemic Index Diet, emphasizing pulses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Cereal Fibre Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low glycemic index diet with pulses</intervention_name>
    <description>Subjects will be advised to follow a diabetic diet, using low glycemic index foods, emphasizing pulses.</description>
    <arm_group_label>Low glycemic Index Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Cereal Fibre</intervention_name>
    <description>Subjects will be advised to follow a healthy high fibre diabetic diet.</description>
    <arm_group_label>High Cereal Fibre Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Men and women with type 2 diabetes who&#xD;
&#xD;
          -  are treated with oral hypoglycemic agents at a stable dose for at least 8 weeks&#xD;
&#xD;
          -  have a HbA1c in the range of 6.5% to 8.5% at screening and at the visit prior to&#xD;
             randomization&#xD;
&#xD;
          -  have diabetes diagnosed &gt;6 months&#xD;
&#xD;
          -  have maintained stable weight for 2 months (within 3%)&#xD;
&#xD;
          -  have a valid OHIP card and a family physician&#xD;
&#xD;
          -  if prescribed lipid medication, have taken a stable dose for at least 2 weeks&#xD;
&#xD;
          -  if prescribed blood pressure medication, have taken a stable dose for at least 1 week&#xD;
&#xD;
          -  can keep written food records, with the use of a digital scale&#xD;
&#xD;
        Exclusion Criteria: Individuals who&#xD;
&#xD;
          -  take insulin&#xD;
&#xD;
          -  take steroids&#xD;
&#xD;
          -  have GI disease (gastroparesis, celiac disease, ulcerative colitis, Crohn's Disease,&#xD;
             IBS)&#xD;
&#xD;
          -  have had a major cardiovascular event (stroke or myocardial infarction) in the past 6&#xD;
             months&#xD;
&#xD;
          -  take warfarin (Coumadin)&#xD;
&#xD;
          -  have had major surgery in the past 6 months&#xD;
&#xD;
          -  have a major debilitating disorder&#xD;
&#xD;
          -  have clinically significant liver disease (AST or ALT &gt; 130 U/L), excluding NAFL or&#xD;
             NASH&#xD;
&#xD;
          -  have hepatitis B or C&#xD;
&#xD;
          -  have renal failure (high creatinine &gt; 150 mmol/L)&#xD;
&#xD;
          -  have serum triglycerides â‰¥ 6.0 mmol/L&#xD;
&#xD;
          -  have a history of cancer, except non-melanoma skin cancer (basal cell, squamous cell)&#xD;
&#xD;
          -  have food allergies to study food components&#xD;
&#xD;
          -  have elevated blood pressure (&gt; 145/90) unless approved by GP&#xD;
&#xD;
          -  have acute or chronic infections (bacterial or viral)&#xD;
&#xD;
          -  have chronic inflammatory diseases (e.g. rheumatoid arthritis, lupus; ulcerative&#xD;
             colitis)&#xD;
&#xD;
          -  have other conditions which in the opinion of any of the investigators would make them&#xD;
             unsuitable for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>February 3, 2010</study_first_submitted>
  <study_first_submitted_qc>February 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2010</study_first_posted>
  <last_update_submitted>December 7, 2015</last_update_submitted>
  <last_update_submitted_qc>December 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>David Jenkins</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

